Noticeably, SOX5 siRNA alone significantly regressed tumor growth than control siRNA (p < 0.05), but the combination group exhibited a greater degree of tumor regression compared to SOX5 siRNA alone, paralleling in vitro results. The gene discussed is SOX5; the disease is neoplasm.